… cancer (mCRC) patients treated with bevacizumab and oxaliplatin-based chemotherapy.
Experimental Design: A total of 132 patients treated with first-line bevacizumab and … correlates. …

… Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab
… rash, have been correlated with improved outcomes in patients with non–small cell lung …

… CRC patients treated between 2009 and 2017 outside of a clinical … patients who used
bevacizumab as first-line and second-line … and negatively correlated with delayed bevacizumab …

… CA 19-9 levels with the clinical outcome of mCRC patients treated with first-line
bevacizumab-based … ET-1 levels were strongly correlated with the clinical outcome of mCRC …

… Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated
with first-line bevacizumab. … in colorectal cancer patients treated with first-line bevacizumab. …

… , clinical trials (5-7). Based on these results, BV was approved for the first-line and second-line
treatment of … , and no correlation was observed between remaining primary tumors and …

… phase 3 trial in patients with metastatic colorectal cancer. Results of … of bevacizumab to
chemotherapy increases treatment efficacy. … plus bevacizumab in patients with colorectal cancer. …

… VEGF is expressed in a wide variety of tumour types and tumour VEGF levels often correlate
… In a pivotal phase III trial of first-line bevacizumab (5 mg/kg every 2 weeks) in combination …

… antibody targeting the vascular endothelial growth factor (… -line treatment of colorectal
cancer and in the first-line treatment of … has been correlated with worse clinical outcome.[11,12,13] …

… Although it has been reported that there is a correlation between exposure to 3 highly … in
patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a …